NASDAQ: ALLO

Market Summary

ALLO’s Q2 earnings estimates: What investors need to know

Preston Campbell

Allogene Therapeutics Inc (ALLO)’s stock is trading at $1.71 at the moment marking a fall of -0.29% from the last ...

Stocks Trading

The Allogene Therapeutics Inc (ALLO) Stock Is Headed for a Correction

Preston Campbell

In the current trading session, Allogene Therapeutics Inc’s (ALLO) stock is trading at the price of $1.37, a fall of ...

Stocks Trading

ALLO’s earnings estimates: Are they on track to meet expectations?

Preston Campbell

In the current trading session, Allogene Therapeutics Inc’s (ALLO) stock is trading at the price of $1.45, a gain of ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.